CSI CONFERENCE HUB
Read More
ARCH Conference
Upcoming Conferences
CSI Product Portfolio
upcoming conferences
April 14-17, 2021
Read More
CRT Virtual Conference
February 13 - April 24, 2021
Read More
Northwell Health Fellows Conference
April 23-25, 2021
Read More
SCAI Conference
April 28-May 1, 2021
Read More
CRF Fellows Conference
May 7-9, 2021
Click here for more information
International Conferences
CSI Product portfolio
Diamondback 360® Coronary Orbital Atherectomy System
Diamondback 360® Peripheral Orbital Atherectomy System
Diamondback 360® Exchangeable Series
Sapphire® Balloons
TELEPORT® MICROCATHETER
ZILIENT® PERIPHERAL GUIDEWIRE
DIAMONDBACK 360® CORONARY ORBITAL ATHERECTOMY SYSTEM
Diamondback 360 Coronary Orbital Atherectomy System’s (OAS) unique mechanism of action uses a patented combination of centrifugal force and differential sanding to safely and simply reduce arterial calcium, enabling successful stent delivery.
Learn More
DIAMONDBACK 360® PERIPHERAL ORBITAL ATHERECTOMY SYSTEM
Expand your PAD treatment options with multiple access solutions and low profile advantages of the revolutionary Diamondback 360 Peripheral Orbital Atherectomy device. The low profile design facilitates minimally invasive treatment options for those with peripheral artery disease.
Learn More
DIAMONDBACK 360® PERIPHERAL ORBITAL ATHERECTOMY SYSTEM – EXCHANGEABLE SERIES
The Diamondback 360 Exchangeable Series with GlideAssist® is our most advanced OAS on the market for complete leg revascularization.
The next gen device allows you to use multiple crowns with one handle to optimize your approach in treating multi-level disease cases.
Learn More
SAPPHIRE® BALLOON DILATATION CATHETERS
The Sapphire II PRO is a semi-compliant balloon specifically engineered for crossing difficult lesions and tracking tortuous anatomy.
The Sapphire NC Plus combines advanced precision and engineering technologies for optimum reliability and deliverability. A truly non- compliant balloon that takes the pressure with minimal balloon growth for reliable dilatation.
Learn More
TELEPORT® MICROCATHETER
Ultimate control and trackability for guidewire access in the most challenging lesions.
• Ultra low profile and pushability for navigation inside lesions and micro channels
• HYbrid BRAiding + Coil (HYBRACOIL) construction for guidewire support and crossing
• DUal-Layer RAdiopaque (DURA) tapered tip for robustness and visibility
• Indicated for coronary and peripheral interventions
Learn More
ZILIENT® PERIPHERAL GUIDEWIRE
ZILIENT. TRUE TO THE HAND THAT GUIDES IT. Guidewires are the most tactile-based tool you use, forging the pathway to treatment. Our peripheral guidewire portfolio is designed to get to and across the lesion and includes four tip load choices across two diameters.
Learn More
VIPERCATH™ XC PERIPHERAL EXCHANGE CATHETER
VIPERCATH™ XC PERIPHERAL EXCHANGE CATHETER
The longest length exchange catheter available to guide and support guide wire access in the vasculature and allow for wire exchanges while providing a conduit for delivering saline and contrast. Designed for kink resistance, torqueability and support during delivery.
Learn More
Read More
Past Sessions and Presentations
Past Conferences and Sessions
Read More
Peripheral Presentations
Learn More
CSIQ Professional Education
contact us
Past Sessions & presentations
Contact us
Diamondback 360® Coronary Orbital Atherectomy System
Indications Statement: The Diamondback 360® Coronary Orbital Atherectomy System (OAS) is a percutaneous orbital atherectomy system indicated to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for PTCA or stenting due to de novo, severely calcified coronary artery lesions.
Contraindications: The OAS is contraindicated when the ViperWire Advance® Coronary Guide Wire cannot pass across the coronary lesion or the target lesion is within a bypass graft or stent. The OAS is contraindicated when the patient is not an appropriate candidate for bypass surgery, angioplasty, or atherectomy therapy, or has angiographic evidence of thrombus, or has only one open vessel, or has angiographic evidence of significant dissection at the treatment site and for women who are pregnant or children.
Warnings/Precautions: Performing treatment in excessively tortuous vessels or bifurcations may result in vessel damage; The OAS was only evaluated in severely calcified lesions, A temporary pacing lead may be necessary when treating lesions in the right coronary and circumflex arteries; On-site surgical back-up should be included as a clinical consideration; Use in patients with an ejection fraction (EF) of less than 25% has not been evaluated.
See the instructions for use before performing Diamondback 360 Coronary Orbital Atherectomy System procedures for detailed information regarding the procedure, indications, contraindications, warnings, precautions, and potential adverse events.
Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.
Diamondback 360® Peripheral Orbital Atherectomy System
Indications Statement: The Diamondback 360® Peripheral Orbital Atherectomy System is a percutaneous orbital atherectomy system indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and who are acceptable candidates for percutaneous transluminal atherectomy. The OAS supports removal of stenotic material from artificial arteriovenous dialysis fistulae (AV shunt). The system is a percutaneous orbital atherectomy system indicated as a therapy in patients with occluded hemodialysis grafts who are acceptable candidates for percutaneous transluminal angioplasty.
Contraindications: The Systems are contraindicated for use in coronary arteries, bypass grafts, stents, or where thrombus or dissections are present.
Adverse Events: Although the incidence of adverse events is rare, potential events that can occur with atherectomy include: pain, hypotension, CVA/TIA, death, dissection, perforation, distal embolization, thrombus formation, hematuria, abrupt or acute vessel closure, or arterial spasm.
Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.
CSI, Diamondback, Diamondback 360, GlideAssist, ViperSlide, Zilient, ViperWire Advance, and ViperWire are registered trademarks of Cardiovascular Systems, Inc.
Sapphire and Teleport are Registered Trademarks of the OrbusNeich Medical Company Limited or its affiliates. These devices are manufactured by OrbusNeich and distributed by CSI.
©2020 Cardiovascular Systems, Inc. EN-6440.G
Read More
Coronary Presentations
Products listed above are available in the U.S. for sale by or on the order of a physician.
For more information about product availability globally, please click below.
OrbusNeich Medical Co. Ltd.:
APAC (Asia-Pacific)
EMEA (Europe, Middle East, Africa)
Medikit Co., Ltd:
Japan
For more information on the conference, please visit the ARCH website
CSI Activities
ARCH Conference
CSI activities to be added soon!
April 14-17, 2021
For more information on the conference, please visit the Northwell Health Fellows website
CSI Activities
Northwell health fellows Conference
CSI activities to be added soon!
April 23-25, 2021
For more information on the conference, please visit the SCAI website
CSI Activities
SCAI Conference
CSI activities to be added soon!
April 28-May 1, 2021
For more information on the conference, please visit the CRF Fellows website
CSI Activities
CRF Fellows Conference
CSI activities to be added soon!
May 7-9, 2021
TIO Conference
International Conferences
April 14-16, 2021
CSI activities to be added soon!
For more information, please visit the TIO website
May 18-20, 2021
CSI activities to be added soon!
For more information, please visit the EuroPCR website
Euro pcr Conference
April 14-16, 2021
CSI activities to be added soon!
For more information on the conference, please visit the TIO website
TIO Conference
TCT Connect 2020 Conference
past conferences & Sessions
NCVH Symposium - "Optimizing the Patient Experience with Radial PVIs Using Orbital Atherectomy: The REACH PVI Study and Case Reviews" Dr. Ankur Lodha
Home
TCT Advanced Users E-Training - "Be Calculated®: Optimizing Outcomes in Calcific Coronary Disease" Drs. Ziad Ali, Takashi Ashikaga, Jeff Chambers and Richard Shlofmitz
TCT Fellows E-Satellite - "Be Calculated®: A Fellows Strategic Guide to Calcium" Drs. Ziad Ali, Emmanouil Brilakis and Perwaiz Meraj
NCVH Symposium - "Optimizing the Patient Experience with Radial PVIs Using Orbital Atherectomy: The REACH PVI Study and Case Reviews" Dr. Ankur Lodha
TCT Advanced Users Session - "Be Calculated®: Optimizing Outcomes in Calcific Coronary Disease" Drs. Ziad Ali, Takashi Ashikaga, Jeff Chambers and Richard Shlofmitz
CSI Coronary Product Slides
coronary presentations
Orbital Atherectomy System in Treating De Novo, Severely Calcified Coronary Lesions: A Tertiary Center Experience
Home
One Solution
Diamondback 360® Coronary OAS Brochure
CSI Coronary Product Slides
Peripheral Orbital Atherectomy Systems Safety
Why Radial
Benefits of Atherectomy Treatment
peripheral Presentations
Home
One Solution
One Solution PAD Brochure
Benefits of Atherectomy Treatment